MD, MPH | GI/CNS Asst Prof @MCWRadOnc @MCW_IHH | via @RadOncUH @CWRUSOM @SUNYDownstate @AUCMed @ThisIsUIC | 🌈 | Asian/PI Advocate | Global Health/Patient Edu
Milwaukee, WI
Joined May 2013
- Tweets5.2K
- Following1.1K
- Followers828
- Likes9.9K
Pinned Tweet
Honored to share that I’ll be joining @MCWRadOnc with a dual appt with @MCW_IHH as an Assistant Professor next year! So grateful to have the opportunity to work alongside such amazing leaders in radiation oncology, public & global health! So thankful for all my mentors @RadOncUH
Rohan Patel, MD, MPH retweeted
Applying to radonc residency? ☢️
Join @ElianeGarlock for an interactive session with a current #RadOnc resident and 3 PDs from across the country as they share insider perspectives on navigating residency interviews!
Great opportunity to get your questions answered! #Match2027
News from #ASTRO26: Short-course radiation therapy better preserves physical function before pancreatic cancer surgery
Randomized phase 2 trial finds better patient experience with five-treatment option; longer chemoradiation did not significantly improve tumor response or reduce progression.
As seen in @CancerNetwrk, @ASCOPost, @AuntMinnie, & @Medscape. Presented by William A. Hall, MD, from the Medical College of Wisconsin.
Learn more: bit.ly/3TIu2xi
@whallradonc @MCWRadOnc
Rohan Patel, MD, MPH retweeted
An important topic that is frequently discussed during many GI tumor boards.
How do we conceptualize/treat oligoprogressive and OMD?
Thank you @KrishanJethwa for mentoring and working on this with me!
apm.amegroups.org/article/vi…
Rohan Patel, MD, MPH retweeted
The future looks bright with these three outstanding #WomenWhoCurie leading ASTRO.
Dr. Neha Vapiwala is our new Board Chair, Dr. Catheryn Yashar is now ASTRO President and Dr. Beth Erickson is our President-Elect. #ASTRO26
@ASTRO_Chair @NehaVapiwala @catherynyashar @BethEri81895034 @S_W_R_O @ARRO_org @RadOncPDs
Rohan Patel, MD, MPH retweeted
I went to a few of the poster sessions and things were definitely buzzing! Lots of engagement! Fantastic location with easy access to beverage service. 👍
It was really great to see the mix of participants too, from med students to senior faculty to industry. My @MCWRadOnc colleague @RohanPatelMD was so in demand at his station that I could barely say hi to him.
There’s always things to improve upon, but I thought it was a success 👏
Mentors like @DrSpratticus make a world of a difference for your career, and so grateful to have him always in my corner, and to be able to learn and grow as junior faculty with @whallradonc at MCW! And having #ASTRO26 to get a chance to see your people again makes it the best❤️
#ASTRO26
Awesome catching up with @alison_tree @angela_jia_ @HimanshuNagarMD and @RadOncUH former resident @RohanPatelMD who is faculty at MCW with @whallradonc
All of them continue to inspire me!
Rohan Patel, MD, MPH retweeted
#ASTRO2
This is unprecedented speed and precision.
@lauren_henke crushing it @ASTRO_org and showing the world something they have never seen before.
87% speed improvements and can treat a full online adaptive pancreas and 2 high dose liver SBRTs in under 50 minutes full end to end instead of over 3 hrs on ethos today with all the breath holds.
Rohan Patel, MD, MPH retweeted
It’s easy to criticize RT trials for aspirational effect sizes (I’ve done it myself). But these studies v difficult to accrue ($, tech avail off trial).
A smaller effect size can make N infeasible.
Alternative endpoints/stats = potential solutions, but this is current reality.
Rohan Patel, MD, MPH retweeted
Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial
thelancet.com/journals/lanep…
Rohan Patel, MD, MPH retweeted
GI003 HCC proton vs photon: no dif OS, PFS, Gr 3+ AEs.
Protons = 1 option in expanding RT toolbox (MRgRT, adaptive, etc) to optimize therapeutic ratio, & each case should be individualized by tumor & liver fxn.
But w neg RCT & $/access dif, photon RT should remain SOC. #ASTRO26
Rohan Patel, MD, MPH retweeted
ASTRO's Annual Meeting allows you to explore the ways new technology, such as AI, help shape the future of radiation oncology.
Ahead of #ASTRO26, we’re asking our members why they are attending ASTRO’s 68th Annual Meeting.
Last up: Leah Katz, MD, MPH, talks about what she is most looking forward to at ASTRO 2026 and what excites her about the future of AI in #radonc.
Register to join us in Boston or virtually: bit.ly/4y6O0An
@leah_minnie
Rohan Patel, MD, MPH retweeted
@MCWRadOnc Chair @whallradonc featured in @MedicalCollege President Dr Shekar Kurpad’s inaugural address. Theranostics is leading the way!
“Turning collaboration into momentum…”
MCW is a Destination for Health
Such an honor to represent @MCWRadOnc at @IASLC as a member of the Global Policy and Partnerships committee on my 2nd term and chairing my first oral abstract session on Global Health, Health Services and Health Economics at #WCLC26!! What an honor it is to be back in Korea too❤️
Rohan Patel, MD, MPH retweeted
Short-course RT + IO in rectal cancer. Several recent RCTs w high CR rates (esp notable given lower BED of 25Gy/5fx).
Hypothesis: larger fx enhance antitumor immunity & shorter tx duration reduces RT lymphotox.
IMO data compelling enough for large RCT w organ intent. @OncoAlert
1) Raising money for cancer research? ✅
2) Getting to dunk your chair (@whallradonc) & vice chair (Dr. Johnstone) as a fresh junior faculty? ✅✅✅✅
What a wonderful cause & turnout to dunk our @MCWRadOnc leadership! Dw I donated extra $$ to just press the button on Dr. Hall🤣
Rohan Patel, MD, MPH retweeted
Here is a quick 3 min update on NRG GI-011, highlighting Amendment 2.0 changes:
1. Liberalize post-induction chemo CA199 criteria
2. Allow tumor treating fields
3. Up to 8 mo induction chemo
We hope these changes further facilitate accrual.
Thanks to all for your support 🙏!
Rohan Patel, MD, MPH retweeted
A new publication reports a 30-day mortality of 11% among nearly 1,000 pts who underwent histotripsy for primary and metastatic liver tumors. This statistic signals a need for greater scrutiny to clarify the utility and practice patterns of this supposedly "less invasive" treatment.
jamanetwork.com/journals/jam…
Rohan Patel, MD, MPH retweeted
PRO analysis of PLATO anal ca trials. Major early (6-mo) findings:
1) Dose-escalated RT (ACT5): no clear PRO detriment
2) Reduced-dose RT (ACT4): signal for better sexual fxn
3) Baseline stg appeared to drive post-tx symptom burden
Await 36-mo analysis re: late effects @OncoAlert
Rohan Patel, MD, MPH retweeted
🌐 Welcome to @TheCORGILab!
#CORGILab (Collaborative Oncology Research Group International) is a global oncology research collaborative founded by @EChrisDee, bringing together students, trainees, clinicians, and scientists from around the world to advance cancer research, strengthen health systems, and improve cancer outcomes.
Our work is built on three core principles:
🧬 Rigorous science
🤝 Mentorship & collaboration
🎗 Equitable cancer outcomes
We believe that meaningful research happens when diverse perspectives come together across disciplines, career stages, and countries. By fostering collaboration and mentorship, we aim to develop the next generation of investigators while producing research that improves cancer care worldwide.
Follow @TheCORGILab for publications, conference presentations, trainee/member achievements, and opportunities to collaborate.
Collaboration has no borders 🌎🌍🌏
#CancerResearch #GlobalOncology #Oncology #HealthEquity
